No black box warning on record for Veklury

As of the latest FDA labeling reviewed, Veklury (REMDESIVIR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Veklury medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity including infusion-related and anaphylactic reactions: Hypersensitivity reactions have been observed during and following administration of VEKLURY. Slower infusion rates, with a maximum infusion time of up to 120 minutes, can be considered to potentially prevent signs and symptoms of hypersensitivity. Monitor patients during infusion and observe patient

No black box warning on record for Veklury

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity including infusion-related and anaphylactic reactions: Hypersensitivity reactions have been observed during and following administration of VEKLURY. Slower infusion rates, with a maximum infusion time of up to 120 minutes, can be considered to potentially prevent signs and symptoms of hypersensitivity. Monitor patients during infusion and observe patient

Veklury Black Box Warning

No black box warning on record for Veklury

Other warnings & precautions

Veklury Black Box Warning

No black box warning on record for Veklury

Other warnings & precautions